4D Biomaterials | $4,373,097 | (Jul 26, 2024)
Micropep Technologies | $29,000,000 | (Jul 26, 2024)
TRiCares GmbH | $50,000,000 | (Jul 26, 2024)
Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
SirenOpt | $6,600,000 | (Jul 26, 2024)
Jarvis | $2,315,016 | (Jul 26, 2024)
Archera | $17,000,000 | (Jul 26, 2024)
Noded Ai | $4,000,000 | (Jul 26, 2024)
NAVIGANTIS | $12,000,000 | (Jul 26, 2024)
GEOH | $3,000,000 | (Jul 26, 2024)
Addionics | $39,000,000 | (Jul 26, 2024)
Fractile | $15,000,000 | (Jul 26, 2024)
HASH | $10,000,000 | (Jul 26, 2024)